Literature DB >> 10459872

Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies.

N Kato1, T Sugiyama, H Morita, H Kurihara, Y Yamori, Y Yazaki.   

Abstract

BACKGROUND: Accumulating evidence has supported the pathophysiological role of angiotensinogen in essential hypertension. However, some studies of molecular genetics have implicated that there may be an ethnic variation concerning the disease susceptibility of the AGT gene. OBJECTIVES AND METHODS: To evaluate the importance of this candidate gene for hypertension, we undertook an extensive association study in the Japanese. This case-control study was conducted in a total of 1232 individuals consecutively enrolled in a single institution, divided into two subgroups: one subgroup comprised 254 hypertensive and 224 normotensive subjects and the other comprised 463 hypertensive and 291 normotensive subjects. A meta-analysis was subsequently performed on six Japanese studies including the present study.
RESULTS: No significant association was observed between a molecular variant of AGT, Thr235, and hypertension status in our case-control study. Moreover, this finding was extendible to another AGT polymorphism, G-6A, one of the potential functional polymorphisms in the promoter region, because these two polymorphisms proved to be in complete linkage disequilibrium in the studied population. The meta-analysis revealed that the pooled estimate of the odds ratio across the studies was 1.22 (95% CI 1.05-1.42), and that there was significant evidence against homogeneity of the odds ratios among the studies included (phi2 = 19.8, df = 5, P = 0.0014). In particular, a large range of variation (60-83%) was found for the allele frequency of Thr235 among control subjects of the six Japanese case-control studies.
CONCLUSIONS: Although the meta-analysis appears in favour of association between the AGT variant and essential hypertension in the Japanese, there is considerable heterogeneity among the studies and the evidence is also rather borderline. Further comprehensive approaches are needed to resolve this debatable issue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459872     DOI: 10.1097/00004872-199917060-00006

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension.

Authors:  Eros Balam-Ortiz; Adolfo Esquivel-Villarreal; David Huerta-Hernandez; Juan Carlos Fernandez-Lopez; Luis Alfaro-Ruiz; Omar Muñoz-Monroy; Ruth Gutierrez; Enrique Figueroa-Genis; Karol Carrillo; Adela Elizalde; Alfredo Hidalgo; Mauricio Rodriguez; Maki Urushihara; Hiroyuki Kobori; Gerardo Jimenez-Sanchez
Journal:  Hypertension       Date:  2012-02-27       Impact factor: 10.190

2.  Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations.

Authors:  Toshiaki Nakajima; Lynn B Jorde; Tomoaki Ishigami; Satoshi Umemura; Mitsuru Emi; Jean-Marc Lalouel; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2001-11-30       Impact factor: 11.025

3.  Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population.

Authors:  Eros Balam-Ortiz; Adolfo Esquivel-Villarreal; Luis Alfaro-Ruiz; Karol Carrillo; Adela Elizalde; Trinidad Gil; Maki Urushihara; Hiroyuki Kobori; Gerardo Jimenez-Sanchez
Journal:  Am J Med Sci       Date:  2011-09       Impact factor: 2.378

Review 4.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

Review 5.  Kidney disease in African Americans: genetic considerations.

Authors:  Deborah A Price; Errol D Crook
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.